Large Cap Archives - Page 149 of 437

1 minute read

Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings

December 12, 3:04 PM

Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to Botox and similar injections.

ABBV

2 minute read

Stocks Edge Higher, ‘Fear Index’ Plummets To Nearly 3-Year Lows Ahead Of Fed Meeting: What’s Driving Markets Tuesday?

By Piero Cingari

December 12, 2:56 PM

The U.S.

BTC

2 minute read

Weight Loss Drugs’ Trickle Down Effect – Insurer Restrictions Create Access Challenges For Diabetes Patients

By Vandana Singh

December 12, 2:53 PM

There is growing concern among some type 2 diabetes patients over challenges in obtaining reimbursement for medications like Novo Nordisk A/S's (NYSE: NVO) Ozempic amid stricter health plan

LLY

1 minute read

Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition

By Vandana Singh

December 12, 2:03 PM

Pfizer Inc (NYSE: PFE)

MKKGY

1 minute read

Why Is Healthcare Enterprise Centene Stock Trading Higher Today?

By Vandana Singh

December 12, 12:21 PM

Centene Corporation (NYSE: CNC) outlined its 2024 financial guidance and provided updates on its

CNC

1 minute read

Why Is Cancer-Focused C4 Therapeutics Stock Soaring Today?

By Vandana Singh

December 12, 10:10 AM

C4 Therapeutics Inc (NASDAQ: CCCC) has entered into an exclusive license and collaboration agreement with Merck & Co Inc (NYSE: MRK) to develop degrader-antibody conjugates (DACs), an emerging modality d

CCCC

1 minute read

Bristol Myers Squibb Further Diversifies Oncology Portfolio With Mega $8.4B Deal

By Vandana Singh

December 12, 10:00 AM

SystImmune and Bristol Myers Squibb & Co (NYSE: BMY)

ABBV

2 minute read

French Pharma Giant Sanofi Drops Rare Disease Drug Pact As Federal Trade Commission Puts Antitrust Obstacle

By Vandana Singh

December 12, 8:14 AM

Sanofi SA (NASDAQ: SNY) said it is terminating the licensing agreement for Maze Therapeutics Inc.'s treatment for a rare genetic disorder after the Federal Trade Commission (FTC)

SNY

2 minute read

AstraZeneca To Acquire US Respiratory Vaccine Player Icosavax For Over $800M

By Vandana Singh

December 12, 6:55 AM

AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Icosavax Inc (NASDAQ: ICVX) at $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable up

AZN

2 minute read

Apple Unveils ‘Journal’ App In Latest iOS Update, Revolutionizing Digital Diary Keeping

By Piero Cingari

December 11, 5:42 PM

Apple's 'Journal' app transcends traditional text-based journaling with photos, videos, audio recordings, and tailored prompts.

AAPL